November 2002
Cover Story
More consumers on HMO and integrated-system boards might not bring the benefits that advocates expect, yet some plans do find them helpful.
If drug purchasers are so bullish on what the AMCP format can do for them, why don't more of them use it?
Proponents tout personalized care and easy access, and imply superior health care. Critics fear "elitist"practices.
A new urgency means that tiered formularies and higher copayments will become even more widespread, a recent survey indicates.
Peer-Reviewed
Editor's Memo
Legislation & Regulation
Compensation Monitor
The Formulary Files
Legal Forum
Managed Care Outlook
Follow us
Popular Content
- How Doctors Are Paid Now, And Why It Has to Change
- Are We on the Way to a Real ‘Learning Health Care System’?
- Herzlinger Predicts ACOs, PCMHs Will Fail
- What the Primary Care Physician Shortage Means for Health Plans
- Disruptive Innovations That Will Change Your Life in Health Care
- Trisomy 21 DNA Test (MaterniT21) for Detecting Down Syndrome in the First Trimester
- First Impressions
- Ten Practical Pointers For Tracking HEDIS Data
- What Makes Harvard Pilgrim So Good?
- More on Less
Medical Directors Forum Webinar
Recent blog posts
- Small Businesses Look at Health Care Changes and Say ‘Duh!’
- First Impressions
- So Much Data, So Few IT Workers
- Meaningful Use Standards Not Being Met
- More on Less
- Plans Confident They Can Handle Exchanges
- Amgen Move Gives Biosimilars Big Boost
- Defining Nondiscriminatory Wellness Programs Remains a Work in Progress
- Banning Indoor Smoking Helps Kids With Asthma
- You've Got a Friend
